Early Access — free while we kick the tires
EdgarHawk

Malley Thomas

Director

Director
1 filing analyzed · 1 company · Latest 2025-08-14

Companies

Company Buys Sells Direction
Kiniksa Pharmaceuticals International, plc KNSA 0 10 Net selling

Activity

August 2025
Sell
177,769 shares
$5,859,815
Significance 7/10

Director Malley Thomas sold 177,769 shares of KNSA in 3 separate sales (Aug 12–14) for $5,859,815.05, reducing holdings by 93.4%.

Director Malley Thomas executed 3 separate sales totaling 177,769 shares for $5,859,815.05 over three consecutive trading days (Aug 12–14), with transaction prices ranging from $32.40 to $33.32. This represents a 93.4% reduction in holdings, from 190,315 shares pre-transaction to 12,546 shares post-transaction. The multi-day execution across a narrow price window ($32.40–$33.32, blended average $32.96) occurred near the stock's 52-week high of $33.65, and the company's recent quarterly revenue of $156,800,000.00 and net income of $17,800,000.00 contrast with a full-year net loss in the most recent completed fiscal year. The combination of near-total position liquidation by a director, strong recent price momentum (30-day change: +18.5%; 90-day change: +26.8%), and the disparity between improving recent profitability and prior-year losses warrants close attention to the underlying business fundamentals and any forward-looking guidance.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access